The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview
Cells · 04.06.2025 · 14 (11) · 839
DOI: 10.3390/cells14110839 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.06.2025. Verfasst von Danish Sultan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Pulmonary Hypertension…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hypertension, Pulmonary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO, NWA-ORC project CIRCULAR NWO, ERC (European Research Council).
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a progressive lung disease characterized by abnormal pulmonary vascular pressure and right ventricular (RV) dysfunction. Atrial arrhythmias, including atrial fibrillation (AF) and atrial flutter, are common in patients with PH and significantly contribute to disease progression and mortality. A bidirectional pathophysiological link exists between PH and AF, encompassing shared mechanisms such as endothelial dysfunction, DNA damage, autophagy, inflammation, and oxidative stress, as well as mutual risk factors, including diabetes, obesity, heart disease, and aging. Despite these shared pathways, limited research has been conducted to fully understand the intertwined relationship between PH and AF, hindering the development of effective treatments. In this review, we provide a comprehensive overview of the epidemiology of PH, the molecular mechanisms underlying the development of AF in PH, and the overlap in their pathophysiology. We also identify novel druggable targets and propose mechanism-based therapeutic approaches to treat this specific patient group. By shedding light on the molecular connection between PH and AF, this review aims to fuel the design and validation of innovative treatments to address this challenging comorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Pulmonary Hypertension and Thrombosis, 1081 HZ Amsterdam, The Netherlands.
ORCID-Profile: Bianca J J M Brundel, Kondababu Kurakula
Förderung
- NWO
- NWA-ORC project CIRCULAR NWO
- ERC (European Research Council)
- Amsterdam University Medical Center
Zitieren
APA
Sultan, D., Brundel, B. J. J. M., & Kurakula, K. (2025). The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview. Cells, 14(11), 839. https://doi.org/10.3390/cells14110839
Vancouver
Sultan D, Brundel BJJM, Kurakula K. The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview. Cells. 2025;14(11):839. doi:10.3390/cells14110839
BibTeX
@article{Sultan2025,
author = {Sultan, Danish and Brundel, Bianca J J M and Kurakula, Kondababu},
title = {The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview},
journal = {Cells},
year = {2025},
volume = {14},
number = {11},
pages = {839},
doi = {10.3390/cells14110839}
}
EUVIMED